Ham, H.* ; Jing, H.* ; Lamborn, I.T.* ; Kober, M.M.* ; Koval, A.* ; Berchiche, Y.A.* ; Anderson, D.E.* ; Druey, K.M.* ; Mandl, J.N.* ; Isidor, B.* ; Ferreira, C.R.* ; Freeman, A.F.* ; Ganesan, S.* ; Karsak, M.* ; Mustillo, P.J.* ; Teo, J.* ; Zolkipli-Cunningham, Z.* ; Chatron, N.* ; Lecoquierre, F.* ; Oler, A.J.* ; Schmid, J.P.* ; Kuhns, D.B.* ; Xu, X.* ; Hauck, F.* ; Al-Herz, W.* ; Wagner, M. ; Terhal, P.A.* ; Muurinen, M.* ; Barlogis, V.* ; Cruz, P.* ; Danielson, J.* ; Stewart, H.* ; Loid, P.* ; Rading, S.* ; Keren, B.* ; Pfundt, R.* ; Zarember, K.A.* ; Vill, K.* ; Potocki, L.* ; Olivier, K.N.* ; Lesca, G.* ; Faivre, L.* ; Wong, M.* ; Puel, A.* ; Chou, J.* ; Tusseau, M.* ; Moutsopoulos, N.M.* ; Matthews, H.F.* ; Simons, C.* ; Taft, R.J.* ; Soldatos, A.* ; Masle-Farquhar, E.* ; Pittaluga, S.* ; Brink, R.* ; Fink, D.L.* ; Kong, H.H.* ; Kabat, J.* ; Kim, W.S.* ; Bierhals, T.* ; Meguro, K.* ; Hsu, A.P.* ; Gu, J.* ; Stoddard, J.* ; Banos-Pinero, B.* ; Slack, M.* ; Trivellin, G.* ; Mazel, B.* ; Soomann, M.* ; Li, S.* ; Watts, V.J.* ; Stratakis, C.A.* ; Rodriguez-Quevedo, M.F.* ; Bruel, A.L.* ; Lipsanen-Nyman, M.* ; Saultier, P.* ; Jain, R.* ; Lehalle, D.* ; Torres, D.* ; Sullivan, K.E.* ; Barbarot, S.* ; Neu, A.* ; Duffourd, Y.* ; Similuk, M.* ; McWalter, K.* ; Blanc, P.D.* ; Bézieau, S.* ; Jin, T.* ; Geha, R.S.* ; Casanova, J.L.* ; Mäkitie, O.M.* ; Kubisch, C.* ; Edery, P.* ; Christodoulou, J.* ; Germain, R.N.* ; Goodnow, C.C.* ; Sakmar, T.P.* ; Billadeau, D.D.* ; Küry, S.* ; Katanaev, V.L.* ; Zhang, Y.* ; Lenardo, M.J.* ; Su, H.C.*
Germline mutations in a G protein identify signaling cross-talk in T cells.
Science 385:eadd8947 (2024)
Humans with monogenic inborn errors responsible for extreme disease phenotypes can reveal essential physiological pathways. We investigated germline mutations in GNAI2, which encodes Gαi2, a key component in heterotrimeric G protein signal transduction usually thought to regulate adenylyl cyclase-mediated cyclic adenosine monophosphate (cAMP) production. Patients with activating Gαi2 mutations had clinical presentations that included impaired immunity. Mutant Gαi2 impaired cell migration and augmented responses to T cell receptor (TCR) stimulation. We found that mutant Gαi2 influenced TCR signaling by sequestering the guanosine triphosphatase (GTPase)-activating protein RASA2, thereby promoting RAS activation and increasing downstream extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)-AKT S6 signaling to drive cellular growth and proliferation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Adenylyl-cyclase; Crystal-structure; Alpha-subunit; Activation; Beta; Inhibition; Mechanism; Binding; Impact; Ras
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
0036-8075
e-ISSN
1095-9203
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 385,
Issue: 6715,
Pages: ,
Article Number: eadd8947
Supplement: ,
Series
Publisher
American Association for the Advancement of Science (AAAS)
Publishing Place
1200 New York Ave, Nw, Washington, Dc 20005 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-503200-001
Grants
Copyright
Erfassungsdatum
2024-10-29